Restlessness and aggression are a particular burden not only for those affected, but especially for the caregivers of people who are suffering from Alzheimer’s disease. These symptoms, which include anxiety, irritability, depression, apathy, disinhibition, delusions and hallucinations, and disturbances of sleep and appetite, are summarized as Behavioral and Psychological Symptoms of Dementia (BPSD).
In the current issue of the prestigious British medical journal Lancet (published September 19, 2015) a remarkable editorial entitled „Alzheimergate? When miscommunication met sensationalism“ was published. In this editorial reference is made to an article that was published on September 10, 2015, in the no less prestigious science journal Nature, which apparently for many journalists suggested that Alzheimer’s disease is contagious in humans. What had happened? Continue reading
In the February issue of Nature Reviews Drug Discovery a brief overview of the new drugs, which have been approved by the Food and Drug Administration (FDA) in 2012, was published under the heading “2012 FDA drug approvals” (Mullard, Nat Rev Drug Disccov 2012, 12: 87-90). A total of 39 new drugs were approved, which is the highest number of new registrations since 1997. Continue reading
The “Antidementia Drugs” are not discussed in the chapter “Psychotropic Drugs” of the Drug Prescription Report 2012 (see my posts from November 9th, 2012, from December 16th, 2012 and from January 19th, 2013), but in a separate chapter. This chapter was not written by Martin Lohse and Bruno Müller-Oerlinghausen but Ulrich Schwabe, one of the two editors of the Drug Prescription Report. Different from the chapter “Psychotropic Drugs”, the chapter on “Antidementia Drugs” is written objectively and scientifically throughout.
Prescription of antidementia drugs has changed considerably in the last decade in Germany.